ONCY
Oncolytics Biotech
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
ONCY Profile
Oncolytics Biotech Inc.
A Canadian company that develops oncolytic viruses for the treatment of cancers
Biological Technology
04/02/1998
06/01/2018
NASDAQ Stock Exchange
28
12-31
Common stock
804, 322 11th Avenue SW, Calgary, Alberta, Canada T2R 0C5
--
Oncolytics Biotech Inc., was incorporated on April 2, 1998 under the laws of Alberta as an Alberta limited liability company. The company is a clinical-stage biopharmaceutical company developing pelareorep, a safe and well-tolerated intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This improves the immune system's ability to fight cancer, making tumors more vulnerable to extensive tumor treatment.